» Articles » PMID: 35249412

Treatment of Redo-microvascular Decompression or Internal Neurolysis Plus Microvascular Decompression for Recurrent Trigeminal Neuralgia: a Review of Long-term Effectiveness and Safety

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2022 Mar 7
PMID 35249412
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We examined the clinical characteristics and outcomes of patients with recurrent trigeminal neuralgia (TN) and assessed the long-term efficacy and safety of microvascular decompression (MVD) to treat typical recurrent TN.

Methods: We identified 3024 patients who underwent MVD for treatment of TN at the China-Japan Friendship Hospital from March 2009 to December 2020. We retrospectively analyzed the data and outcomes of 137 patients who underwent redo-MVD and 74 patients who did not undergo redo-MVD as the control group. These outcomes were evaluated using the Barrow Neurological Institute scoring system.

Results: Recurrence in 68 of the 137 patients was due to incomplete or absent decompression or new responsible vessels. To ensure thorough pain relief, redo-MVD should include decompression of both the trigeminal root entry zone and the peripheral nerve segments, where blood vessels can cause symptoms. Factors associated with reduced effectiveness of redo-MVD were no period of initial pain relief after the first MVD and a longer duration of symptoms before the first MVD.

Conclusions: Redo-MVD should not be excluded as a treatment option for patients with refractory TN who develop recurrent pain after a first MVD procedure.

Citing Articles

Circumferential nerve wrapping with muscle autograft: a modified strategy of microvascular decompression for trigeminal neuralgia.

Paolini S, Mancarella C, Scafa A, Arcidiacono U, Morace R, Chiarella V Neurosurg Rev. 2025; 48(1):32.

PMID: 39789374 DOI: 10.1007/s10143-024-03100-w.


Pathophysiology and Management of Refractory Trigeminal Neuralgia.

Stern J, Ali R, Chiang C, Robertson C Curr Neurol Neurosci Rep. 2024; 25(1):10.

PMID: 39665844 DOI: 10.1007/s11910-024-01387-2.


Association of concomitant continuous pain in trigeminal neuralgia with a narrow foramen ovale.

Li S, Liao C, Yang X, Zhang W Front Neurol. 2023; 14:1277654.

PMID: 38020635 PMC: 10644226. DOI: 10.3389/fneur.2023.1277654.

References
1.
Amador N, Pollock B . Repeat posterior fossa exploration for patients with persistent or recurrent idiopathic trigeminal neuralgia. J Neurosurg. 2008; 108(5):916-20. DOI: 10.3171/JNS/2008/108/5/0916. View

2.
Di Stefano G, Truini A, Cruccu G . Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. Drugs. 2018; 78(14):1433-1442. PMC: 6182468. DOI: 10.1007/s40265-018-0964-9. View

3.
Capelle H, Brandis A, Tschan C, Krauss J . Treatment of recurrent trigeminal neuralgia due to Teflon granuloma. J Headache Pain. 2010; 11(4):339-44. PMC: 3476345. DOI: 10.1007/s10194-010-0213-4. View

4.
Zhang X, Xu L, Zhao H, Tang Y, Zhu J, Yuan Y . Long-Term Efficacy of Nerve Combing for Patients with Trigeminal Neuralgia and Failed Prior Microvascular Decompression. World Neurosurg. 2017; 108:711-715. DOI: 10.1016/j.wneu.2017.09.081. View

5.
Jannetta P . Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. 1967. J Neurosurg. 2007; 107(1):216-9. DOI: 10.3171/JNS-07/07/0216. View